Alvotech (NASDAQ: ALVO)
$14.26
(0.8%)
$0.11
Price as of April 29, 2024, 1:42 p.m. ET
Alvotech Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Alvotech Company Info
Alvotech operates as a global biopharmaceutical company, which engages in developing and manufacturing biosimilar medicines. It operates through the following geographical segments: North America, Europe, Asia, and Other. The company was founded by Róbert Wessman on August 23, 2021 and is headquartered in Luxembourg.
News & Analysis
Featured Article
Why Shares of Alvotech Are Jumping Friday
The biosimilar drug company's shares rebounded a day after it announced that the FDA had dealt it setback.
Jim Halley | Jun 30, 2023
Featured Article
Why Shares of Alvotech Jumped This Week
The Icelandic biotech company has a deal to expand the reach of its Humira biosimilar in Eastern Europe.
Jim Halley | Dec 8, 2022
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.